Structures by: Marzouk A. A.
Total: 26
3-[(3,5-Dimethyl-1<i>H</i>-pyrazol-1-yl)methyl]-4-(4-methylphenyl)-4,5-dihydro-1<i>H</i>-1,2,4-triazole-5-thione
C15H17N5S
IUCrData (2017) 2, 2 x170153
a=7.9322(2)Å b=15.2415(4)Å c=13.6694(4)Å
α=90° β=106.3160(10)° γ=90°
5-{[5-(4-Chlorophenyl)-3-methyl-1<i>H</i>-pyrazol-1-yl]methyl}-1,3,4-oxadiazole-2(3<i>H</i>)-thione
C13H11ClN4OS
IUCrData (2017) 2, 2 x170176
a=4.9309(2)Å b=17.1173(8)Å c=16.6517(7)Å
α=90° β=91.189(3)° γ=90°
4-Cyclohexyl-3-[(3,5-dimethyl-1<i>H</i>-pyrazol-1-yl)methyl]-4,5-dihydro-1-<i>H</i>-1,2,4-triazole-5-thione
C14H21N5S
IUCrData (2017) 2, 1 x170020
a=20.7954(6)Å b=6.2107(2)Å c=11.7871(3)Å
α=90° β=90.6530(10)° γ=90°
2-[4,5-Diphenyl-2-(pyridin-4-yl)-1<i>H</i>-imidazol-1-yl]ethanol
C22H19N3O
IUCrData (2017) 2, 1 x170132
a=5.7619(2)Å b=22.1304(6)Å c=13.6271(4)Å
α=90° β=99.1020(10)° γ=90°
1-[2-(4-Chlorophenyl)-4,5-diphenyl-1<i>H</i>-imidazol-1-yl]propan-2-ol
C24H21ClN2O
Acta Crystallographica Section E (2017) 73, 1 59-62
a=12.0235(8)Å b=13.4263(7)Å c=13.6588(4)Å
α=90.297(3)° β=98.481(4)° γ=110.480(5)°
1-[2-(4-Nitrophenyl)-4,5-diphenyl-1<i>H</i>-imidazol-1-yl]propan-2-ol
C24H21N3O3
Acta Crystallographica Section E (2017) 73, 9 1398-1401
a=12.3070(4)Å b=13.2871(4)Å c=13.8499(3)Å
α=90.907(2)° β=100.748(2)° γ=109.938(3)°
1-[2-(2,6-Dichlorophenyl)-4,5-diphenyl-1<i>H</i>-imidazol-1-yl]propan-2-ol
C24H20Cl2N2O
Acta Crystallographica Section E (2015) 71, 5 o299-o300
a=12.1468(4)Å b=8.4194(2)Å c=20.9636(7)Å
α=90° β=90° γ=90°
2-(4-Bromophenyl)-1-pentyl-4,5-diphenyl-1<i>H</i>-imidazole
C26H25BrN2
Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 9 o1417
a=10.665(5)Å b=9.619(5)Å c=21.541(10)Å
α=90° β=91.092(9)° γ=90°
2-(4-Chlorophenyl)-1-pentyl-4,5-diphenyl-1<i>H</i>-imidazole
C26H25ClN2
Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 8 o1243
a=10.471(2)Å b=9.7798(19)Å c=21.682(4)Å
α=90° β=91.080(4)° γ=90°
Prop-2-en-1-yl 4-(4,5-diphenyl-1<i>H</i>-imidazol-2-yl)benzoate
C25H20N2O2
Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 7 o1105-6
a=15.705(5)Å b=14.888(5)Å c=17.589(6)Å
α=90° β=105.151(4)° γ=90°
2-(2,5-Dimethoxyphenyl)-4,5-diphenyl-1-(prop-2-en-1-yl)-1<i>H</i>-imidazole
C26H24N2O2
Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 7 o1098-9
a=8.3117(14)Å b=10.5217(17)Å c=13.425(2)Å
α=105.938(2)° β=101.846(2)° γ=107.772(2)°
2,4,5-Triphenyl-1-(prop-2-en-1-yl)-1<i>H</i>-imidazole
C24H20N2
Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 6 o988-9
a=10.362(3)Å b=8.938(2)Å c=19.387(5)Å
α=90° β=90.340(5)° γ=90°
2-(4-Chlorophenyl)-4,5-diphenyl-1-(prop-2-en-1-yl)-1<i>H</i>-imidazole
C24H19ClN2
Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 6 o875-6
a=10.0916(7)Å b=13.1386(9)Å c=15.6155(10)Å
α=72.9240(10)° β=86.8490(10)° γ=71.8300(10)°
14-Bromo-12-chloro-2,16-dioxapentacyclo[7.7.5.0^1,21^.0^3,8^.0^10,15^]henicosa-3(8),10,12,14-tetraene-7,20-dione
C19H16BrClO4
Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 5 o769-70
a=10.2741(6)Å b=10.2800(6)Å c=15.8581(8)Å
α=90° β=102.073(5)° γ=90°
2-(2,6-Dichlorophenyl)-1-pentyl-4,5-diphenyl-1<i>H</i>-imidazole
C26H24Cl2N2
Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 6 o846-7
a=20.172(6)Å b=15.947(5)Å c=14.500(5)Å
α=90° β=105.293(7)° γ=90°
4-(1-Allyl-4,5-diphenyl-1<i>H</i>-imidazol-2-yl)-<i>N</i>,<i>N</i>-dimethylaniline
C26H25N3
Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 4 o527-8
a=9.4259(7)Å b=10.2028(7)Å c=44.721(3)Å
α=94.711(2)° β=94.096(2)° γ=107.359(2)°
2-[2-(4-Methoxyphenyl)-4,5-diphenyl-1<i>H</i>-imidazol-1-yl]ethanol
C24H22N2O2
Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 4 o474-5
a=14.3570(4)Å b=13.2820(4)Å c=10.7380(3)Å
α=90° β=108.2120(10)° γ=90°
4-Bromo-2-[(<i>E</i>)-(2-fluoro-5-nitrophenyl)iminomethyl]phenol
C13H8BrFN2O3
Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 1 o107
a=4.5082(9)Å b=19.815(4)Å c=13.853(3)Å
α=90° β=95.484(5)° γ=90°
1-{(<i>Z</i>)-[3-(1-Hydroxyethyl)anilino]methylidene}naphthalen- 2(1<i>H</i>)-one
C19H17NO2
Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 1 o106
a=18.9837(10)Å b=4.740(2)Å c=16.105(8)Å
α=90° β=92.927(9)° γ=90°
2-(3,4-Dimethoxyphenyl)-1-pentyl-4,5-diphenyl-1<i>H</i>-imidazole
C28H30N2O2
Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 12 o1833-4
a=8.900(2)Å b=11.915(3)Å c=12.009(3)Å
α=106.757(6)° β=96.007(5)° γ=108.170(6)°
Dibenzo[<i>b</i>,<i>g</i>]indeno[1',2':3,4]fluoreno[1,2-<i>d</i>]oxonine- 5,11,16,21-tetraone
C34H16O5
Acta Crystallographica Section E (2012) 68, 12 o3363-o3364
a=12.230(4)Å b=12.346(3)Å c=16.794(5)Å
α=82.229(7)° β=72.773(6)° γ=81.181(10)°
2-(4-Methoxyphenyl)-1-pentyl-4,5-diphenyl-1<i>H</i>-imidazole
C27H28N2O
Acta Crystallographica Section E (2013) 69, 1 o5-o6
a=9.7214(19)Å b=10.7390(10)Å c=11.7367(10)Å
α=114.069(4)° β=99.021(6)° γ=95.425(6)°
2-(3,4-Dimethoxyphenyl)-4,5-diphenyl-1-(prop-2-en-1-yl)-1<i>H</i>-imidazole
C26H24N2O2
Acta Crystallographica Section E (2012) 68, 10 o2979-o2980
a=8.9683(4)Å b=10.7916(5)Å c=11.7219(5)Å
α=110.174(2)° β=106.267(2)° γ=91.991(3)°
2-(4-Methoxyphenyl)-4,5-diphenyl-1-(prop-2-en-1-yl)-1<i>H</i>-imidazole
C25H22N2O
Acta Crystallographica Section E (2012) 68, 11 o3113-o3114
a=18.3169(7)Å b=9.6142(3)Å c=23.1656(8)Å
α=90° β=99.0261(7)° γ=90°
4-[5-(4-Chlorophenyl)-3-methyl-1<i>H</i>-pyrazol-1-yl]benzenesulfonamide
C16H14ClN3O2S
Acta Crystallographica Section E (2013) 69, 2 o295-o296
a=15.878(5)Å b=8.209(5)Å c=12.953(5)Å
α=90.000° β=91.016(5)° γ=90.000°
3-{[5-(4-Chlorophenyl)-3-methyl-1<i>H</i>-pyrazol-1-yl]methyl}-4-<i>m</i>-tolyl-1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione
C20H18ClN5S
Acta Crystallographica Section E (2013) 69, 6 o936-o937
a=8.328(5)Å b=16.407(5)Å c=14.759(5)Å
α=90.00° β=99.509(5)° γ=90.00°